Evidence suggests that alterations in BDNF/TrkB, including TrkB transactivation by A2aRs, can occur in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). The gene discussed is NTRK2; the disease is amyotrophic lateral sclerosis.